amantadine has been researched along with Depression, Involutional in 12 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Depression, Involutional: Form of depression in those MIDDLE AGE with feelings of ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An aim of a study was to establish the relationship between pain, motor complications and depression in Parkinson's disease and evaluate an effect of the 3 months therapy with the dopamine receptor agonist pramipexole (mirapex)." | 9.13 | [Pain and depression in Parkinson's disease: new therapeutic possibilities of pramipexole]. ( Letvinenko, IV; Mogil'naia, VI; Odinak, MM, 2008) |
| "Amantadine was given twice a day (100-300 mg/day) for a mean of 11 weeks." | 6.69 | Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. ( Bode, L; Brodhun, B; Dietrich, DE; Emrich, HM; Huber, TJ; Lau, T; Ludwig, H; Spannhuth, CW, 2000) |
| "The interventional phase II RCT (two 7-weeks-treatment periods and a 12-months follow-up) at the Hannover Medical School (MHH), Germany, assigned currently depressed BDV-1 infected patients with either major depression (MD; N = 23) or bipolar disorder (BD; N = 13) to amantadine sulphate (PK-Merz®; twice 100 mg orally daily) or placebo treatment, and contrariwise, respectively." | 5.34 | Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial. ( Bode, L; Dietrich, DE; Emrich, HM; Hecker, H; Ludwig, H; Spannhuth, CW, 2020) |
| "An aim of a study was to establish the relationship between pain, motor complications and depression in Parkinson's disease and evaluate an effect of the 3 months therapy with the dopamine receptor agonist pramipexole (mirapex)." | 5.13 | [Pain and depression in Parkinson's disease: new therapeutic possibilities of pramipexole]. ( Letvinenko, IV; Mogil'naia, VI; Odinak, MM, 2008) |
| "Amantadine was given twice a day (100-300 mg/day) for a mean of 11 weeks." | 2.69 | Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. ( Bode, L; Brodhun, B; Dietrich, DE; Emrich, HM; Huber, TJ; Lau, T; Ludwig, H; Spannhuth, CW, 2000) |
| "To assess the quality of life, the Parkinson's Disease Questionnaire (PDQ-39) was used." | 1.32 | Quality of life in Polish patients with long-lasting Parkinson's disease. ( Derejko, M; Friedman, A; Sławek, J; Zach, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dietrich, DE | 2 |
| Bode, L | 2 |
| Spannhuth, CW | 2 |
| Hecker, H | 1 |
| Ludwig, H | 2 |
| Emrich, HM | 2 |
| Letvinenko, IV | 1 |
| Odinak, MM | 1 |
| Mogil'naia, VI | 1 |
| Szakacs, R | 1 |
| Janka, Z | 1 |
| Kalman, J | 1 |
| Bahk, WM | 1 |
| Lee, KU | 1 |
| Chae, JH | 1 |
| Pae, CU | 1 |
| Jun, T | 1 |
| Kim, KS | 1 |
| Zach, M | 1 |
| Friedman, A | 1 |
| Sławek, J | 1 |
| Derejko, M | 1 |
| Rao, V | 1 |
| Handel, S | 1 |
| Vaishnavi, S | 1 |
| Keach, S | 1 |
| Robbins, B | 1 |
| Spiro, J | 1 |
| Ward, J | 1 |
| Berlin, F | 1 |
| Lerner, AJ | 1 |
| Strauss, M | 1 |
| Sami, SA | 1 |
| Goforth, H | 1 |
| Maeng, S | 1 |
| Zarate, CA | 1 |
| Lau, T | 1 |
| Huber, TJ | 1 |
| Brodhun, B | 1 |
| Vallecorsi, G | 1 |
| Bavazzano, A | 1 |
| D'Ayalavalva, G | 1 |
| Montanari, C | 1 |
| Balunov, OA | 1 |
| Bazhin, EF | 1 |
| Morozova, ES | 1 |
| Fedotenkova, TN | 1 |
3 reviews available for amantadine and Depression, Involutional
| Article | Year |
|---|---|
The "blue" side of glutamatergic neurotransmission: NMDA receptor antagonists as possible novel therapeutics for major depression.
Topics: Amantadine; Antidepressive Agents; Depressive Disorder, Major; Glutamates; Hippocampus; Humans; Mema | 2012 |
Recognizing apathy in Alzheimer's disease.
Topics: Affective Symptoms; Aged; Alzheimer Disease; Amantadine; Cognition Disorders; Depressive Disorder, M | 2007 |
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.
Topics: Amantadine; Depressive Disorder, Major; Dopamine Agents; Excitatory Amino Acid Antagonists; Humans; | 2007 |
4 trials available for amantadine and Depression, Involutional
| Article | Year |
|---|---|
Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial.
Topics: Adult; Amantadine; Animals; Antibodies, Viral; Antidepressive Agents; Antigens, Viral; Antiviral Age | 2020 |
[Pain and depression in Parkinson's disease: new therapeutic possibilities of pramipexole].
Topics: Aged; Amantadine; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combi | 2008 |
Open label study of the effect of amantadine on weight gain induced by olanzapine.
Topics: Adult; Amantadine; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body We | 2004 |
Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial.
Topics: Adult; Aged; Amantadine; Antidepressive Agents; Borna Disease; Depressive Disorder, Major; Female; H | 2000 |
5 other studies available for amantadine and Depression, Involutional
| Article | Year |
|---|---|
Quality of life in Polish patients with long-lasting Parkinson's disease.
Topics: Activities of Daily Living; Aged; Amantadine; Antiparkinson Agents; Depressive Disorder, Major; Dopa | 2004 |
Psychiatric sequelae of traumatic brain injury: a case report.
Topics: Adult; Amantadine; Brain Injuries; Clinical Protocols; Cognition Disorders; Cognitive Behavioral The | 2007 |
Amantadine in catatonia due to major depressive disorder in a medically ill patient.
Topics: Adult; Amantadine; Antiparkinson Agents; Catatonia; Depressive Disorder, Major; Electroconvulsive Th | 2007 |
[Use of amantadine in old patients with psychomotor and involutional disorders].
Topics: Age Factors; Aged; Amantadine; Depressive Disorder, Major; Drug Evaluation; Female; Humans; Male; Me | 1976 |
[Use of the Soviet preparation midantan in the treatment of the Parkinsonian syndrome].
Topics: Adult; Aged; Amantadine; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle | 1974 |